DiCE Molecules bags $80M in a Series C
The financing will support the progression of DiCE’s IL-17 antagonist into clinical trials
immunology
A new inflammatory disease option
Data supporting Applied Molecular Transport's AMT-101 in treating inflammatory diseases published in The Journal of Immunology
Best of Immuno-oncology
Download DDN’s “Best of Immuno-oncology” ebook to learn more about recent research in cancer immunotherapy. This ebook includes stories about antibody approaches for treating cancer, the potential of CAR-T therapies, precision cancer immunotherapy directed by immune-profiling, and cancer neoepitope discovery.
